메뉴 건너뛰기




Volumn 150, Issue 1, 2005, Pages 79-88

Tenecteplase and tirofiban in ST-segment elevation acute myocardial infarction: Results of a randomized trial

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; TENECTEPLASE; TIROFIBAN;

EID: 19944426630     PISSN: 00028703     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ahj.2005.01.007     Document Type: Article
Times cited : (15)

References (23)
  • 1
    • 0033152273 scopus 로고    scopus 로고
    • Abciximab facilitates the rate and extent of thrombolysis: Results of the thrombolysis in myocardial infarction (TIMI) 14 trial
    • E.M. Antman, R.P. Giugliano, and C.M. Gibson Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial Circulation 99 1999 2720 2732
    • (1999) Circulation , vol.99 , pp. 2720-2732
    • Antman, E.M.1    Giugliano, R.P.2    Gibson, C.M.3
  • 2
    • 0343798542 scopus 로고    scopus 로고
    • Trial of abciximab with and without low-dose reteplase for acute myocardial infarction
    • The SPEED Study Group
    • The SPEED Study Group Trial of abciximab with and without low-dose reteplase for acute myocardial infarction Circulation 101 2000 2788 2794
    • (2000) Circulation , vol.101 , pp. 2788-2794
  • 3
    • 0037028598 scopus 로고    scopus 로고
    • Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: The integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial
    • S.J. Brener, U. Zeymer, and A.A. Adgey Eptifibatide and low-dose tissue plasminogen activator in acute myocardial infarction: the integrilin and low-dose thrombolysis in acute myocardial infarction (INTRO AMI) trial J Am Coll Cardiol 39 2002 377 386
    • (2002) J Am Coll Cardiol , vol.39 , pp. 377-386
    • Brener, S.J.1    Zeymer, U.2    Adgey, A.A.3
  • 4
    • 0345578676 scopus 로고    scopus 로고
    • Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: Results of the INTEGRIlin and Tenecteplase in acute myocardial Infarction (INTEGRITI) phase II angiographic trial
    • R.P. Giugliano, M.T. Roe, and R.A. Harrington Combination reperfusion therapy with eptifibatide and reduced-dose tenecteplase for ST-elevation myocardial infarction: results of the INTEGRIlin and Tenecteplase in acute myocardial Infarction (INTEGRITI) phase II angiographic trial J Am Coll Cardiol 41 2003 1251 1260
    • (2003) J Am Coll Cardiol , vol.41 , pp. 1251-1260
    • Giugliano, R.P.1    Roe, M.T.2    Harrington, R.A.3
  • 5
    • 0037046221 scopus 로고    scopus 로고
    • Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: Results of the ENTIRE-Thrombolysis in Myocardial Infarction (TIMI) 23 Trial
    • E.M. Antman, H.W. Louwerenburg, and H.F. Baars Enoxaparin as adjunctive antithrombin therapy for ST-elevation myocardial infarction: results of the ENTIRE-Thrombolysis In Myocardial Infarction (TIMI) 23 Trial Circulation 105 2002 1642 1649
    • (2002) Circulation , vol.105 , pp. 1642-1649
    • Antman, E.M.1    Louwerenburg, H.W.2    Baars, H.F.3
  • 6
    • 0034711702 scopus 로고    scopus 로고
    • Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial
    • J.A. de Lemos, E.M. Antman, and C.M. Gibson Abciximab improves both epicardial flow and myocardial reperfusion in ST-elevation myocardial infarction. Observations from the TIMI 14 trial Circulation 101 2000 239 243
    • (2000) Circulation , vol.101 , pp. 239-243
    • De Lemos, J.A.1    Antman, E.M.2    Gibson, C.M.3
  • 7
    • 0023258694 scopus 로고
    • Thrombolysis in Myocardial Infarction (TIMI) Trial, phase I: A comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge
    • J.H. Chesebro, G. Knatterud, and R. Roberts Thrombolysis In Myocardial Infarction (TIMI) Trial, phase I: a comparison between intravenous tissue plasminogen activator and intravenous streptokinase. Clinical findings through hospital discharge Circulation 76 1987 142 154
    • (1987) Circulation , vol.76 , pp. 142-154
    • Chesebro, J.H.1    Knatterud, G.2    Roberts, R.3
  • 8
    • 9044246670 scopus 로고    scopus 로고
    • TIMI frame count: A quantitative method of assessing coronary artery flow
    • C.M. Gibson, C.P. Cannon, and W.L. Daley TIMI frame count: a quantitative method of assessing coronary artery flow Circulation 93 1996 879 888
    • (1996) Circulation , vol.93 , pp. 879-888
    • Gibson, C.M.1    Cannon, C.P.2    Daley, W.L.3
  • 9
    • 0025851456 scopus 로고
    • Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction
    • E.G. Bovill, M.L. Terrin, and D.C. Stump Hemorrhagic events during therapy with recombinant tissue-type plasminogen activator, heparin, and aspirin for acute myocardial infarction Ann. Intern. Med. 115 1991 256 265
    • (1991) Ann. Intern. Med. , vol.115 , pp. 256-265
    • Bovill, E.G.1    Terrin, M.L.2    Stump, D.C.3
  • 10
    • 0032578970 scopus 로고    scopus 로고
    • TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: Results of the TIMI 10B trial
    • C.P. Cannon, C.M. Gibson, and C.H. McCabe TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial Circulation 98 1998 2805 2814
    • (1998) Circulation , vol.98 , pp. 2805-2814
    • Cannon, C.P.1    Gibson, C.M.2    McCabe, C.H.3
  • 11
    • 0033695759 scopus 로고    scopus 로고
    • Combination reperfusion therapy with abciximab and reduced dose reteplase: Results from TIMI 14
    • E.M. Antman, C.M. Gibson, and J.A. de Lemos Combination reperfusion therapy with abciximab and reduced dose reteplase: results from TIMI 14 Eur Heart J 21 2000 1944 1953
    • (2000) Eur Heart J , vol.21 , pp. 1944-1953
    • Antman, E.M.1    Gibson, C.M.2    De Lemos, J.A.3
  • 12
    • 0030664732 scopus 로고    scopus 로고
    • Differential effects of anticoagulants on the activation of platelets ex vivo
    • D.J. Schneider, P.B. Tracy, and K.G. Mann Differential effects of anticoagulants on the activation of platelets ex vivo Circulation 96 1997 2877 2883
    • (1997) Circulation , vol.96 , pp. 2877-2883
    • Schneider, D.J.1    Tracy, P.B.2    Mann, K.G.3
  • 13
    • 0030610564 scopus 로고    scopus 로고
    • 2+ on GP IIb-IIIa interactions with integrilin: Enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate
    • 2+ on GP IIb-IIIa interactions with integrilin: enhanced GP IIb-IIIa binding and inhibition of platelet aggregation by reductions in the concentration of ionized calcium in plasma anticoagulated with citrate Circulation 96 1997 1488 1494
    • (1997) Circulation , vol.96 , pp. 1488-1494
    • Phillips, D.R.1    Teng, W.2    Arfsten, A.3
  • 14
    • 0036498633 scopus 로고    scopus 로고
    • Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions
    • S.S. Kabbani, A. Aggarwal, and E.F. Terrien Suboptimal early inhibition of platelets by treatment with tirofiban and implications for coronary interventions Am J Cardiol 89 2002 647 650
    • (2002) Am J Cardiol , vol.89 , pp. 647-650
    • Kabbani, S.S.1    Aggarwal, A.2    Terrien, E.F.3
  • 15
    • 0343376106 scopus 로고    scopus 로고
    • The effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty
    • The RESTORE Investigators
    • The RESTORE Investigators The effects of platelet glycoprotein IIb/IIIa blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty Circulation 96 1997 1445 1453
    • (1997) Circulation , vol.96 , pp. 1445-1453
  • 16
    • 0035927988 scopus 로고    scopus 로고
    • Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization
    • E.J. Topol, D.J. Moliterno, and H.C. Herrmann Comparison of two platelet glycoprotein IIb/IIIa inhibitors, tirofiban and abciximab, for the prevention of ischemic events with percutaneous coronary revascularization N Engl J Med 344 2001 1888 1894
    • (2001) N Engl J Med , vol.344 , pp. 1888-1894
    • Topol, E.J.1    Moliterno, D.J.2    Herrmann, H.C.3
  • 17
    • 0035967496 scopus 로고    scopus 로고
    • Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: Results of the GOLD (AU-Assessing Ultegra) multicenter study
    • S.R. Steinhubl, J.D. Talley, and G.A. Braden Point-of-care measured platelet inhibition correlates with a reduced risk of an adverse cardiac event after percutaneous coronary intervention: results of the GOLD (AU-Assessing Ultegra) multicenter study Circulation 103 2001 2572 2878
    • (2001) Circulation , vol.103 , pp. 2572-2878
    • Steinhubl, S.R.1    Talley, J.D.2    Braden, G.A.3
  • 18
    • 0037114844 scopus 로고    scopus 로고
    • Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban
    • D.J. Schneider, H.C. Herrmann, and N. Lakkis Enhanced early inhibition of platelet aggregation with an increased bolus of tirofiban Am J Cardiol 90 2002 1421 1423
    • (2002) Am J Cardiol , vol.90 , pp. 1421-1423
    • Schneider, D.J.1    Herrmann, H.C.2    Lakkis, N.3
  • 19
    • 0037310526 scopus 로고    scopus 로고
    • Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban
    • D.J. Schneider, H.C. Herrmann, and N. Lakkis Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban Am J Cardiol 91 2003 334 336
    • (2003) Am J Cardiol , vol.91 , pp. 334-336
    • Schneider, D.J.1    Herrmann, H.C.2    Lakkis, N.3
  • 20
    • 0035897888 scopus 로고    scopus 로고
    • Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: The GUSTO V randomised trial
    • E.J. Topol Reperfusion therapy for acute myocardial infarction with fibrinolytic therapy or combination reduced fibrinolytic therapy and platelet glycoprotein IIb/IIIa inhibition: the GUSTO V randomised trial Lancet 357 2001 1905 1914
    • (2001) Lancet , vol.357 , pp. 1905-1914
    • Topol, E.J.1
  • 21
    • 0037032380 scopus 로고    scopus 로고
    • Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial
    • A.M. Lincoff, R.M. Califf, and F. Van de Werf Mortality at 1 year with combination platelet glycoprotein IIb/IIIa inhibition and reduced-dose fibrinolytic therapy vs conventional fibrinolytic therapy for acute myocardial infarction: GUSTO V randomized trial JAMA 288 2002 2130 2135
    • (2002) JAMA , vol.288 , pp. 2130-2135
    • Lincoff, A.M.1    Califf, R.M.2    Van De Werf, F.3
  • 22
    • 0035949117 scopus 로고    scopus 로고
    • Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction
    • The ASSENT-3 Investigators
    • The ASSENT-3 Investigators Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: the ASSENT-3 randomised trial in acute myocardial infarction Lancet 358 2001 605 613
    • (2001) Lancet , vol.358 , pp. 605-613


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.